Biofrontera Inc (BFRI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $10.40M
Last updated: Nov 17, 2026 at 11:02 AM ET
Biofrontera Inc (BFRI) Stock Forecast
Analysts expect Biofrontera (BFRI) to earn -$0.18 per share in the fiscal year ending Dec 31, 2026, on revenue of $46.15M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $0.43.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 15.9%.
- Fiscal year ending Dec 31, 2026
- -$0.18
- EPS consensus, revenue $46.15M
- Fiscal year ending Dec 31, 2027
- $0.43
- EPS consensus, revenue $53.47M
- Next report
- Mar 16, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.18 | -$0.18 to -$0.18 | 1 | $46.15M | $45.89M to $46.40M | 2 |
| Dec 31, 2027 | $0.43 | $0.43 to $0.43 | 1 | $53.47M | $53.30M to $53.65M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.32 | $0.30 to $0.33 | 3 | $16.12M | $15.48M to $16.59M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.16.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.18 | -$0.18 | -$0.18 | -$0.16 | -$0.16 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.43 | $0.43 | $0.43 | $0.32 | $0.32 | +34.4% |
Frequently Asked Questions About BFRI
What is the BFRI stock forecast?
Consensus analyst estimates put Biofrontera's EPS at -$0.18 for the fiscal year ending Dec 31, 2026, on revenue of $46.15M.
What EPS do analysts expect from BFRI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.18, with estimates from -$0.18 to -$0.18 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.43, with estimates from $0.43 to $0.43 from 1 analyst.
What revenue do analysts expect from Biofrontera next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $46.15M, with estimates from $45.89M to $46.40M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $53.47M, with estimates from $53.30M to $53.65M.
How many analysts cover BFRI?
1 analyst estimates EPS for Biofrontera for the fiscal year ending Dec 31, 2026.
BFRI pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts